SCHEMBL1317849

SCHEMBL1317849

N#Cc1ccc(-c2cc(N3CCC[C@H](C(=O)Nc4ccc(F)c(F)c4)C3)nc(N)n2)cc1F

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 4/20 0.55
ROCK1 Q13464 3/20 0.55
AURKB Q96GD4 3/20 0.55
AURKA O14965 2/20 0.55
EGLN2 Q96KS0 6/20 0.46
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 1/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CHRM4 P08173 1/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 1/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
KDM1A O60341 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1319542 0.93 PDPK1 (0.56) PDPK1ROCK1AURKBAURKAEGLN2
SCHEMBL1318322 0.93 PDPK1 (0.58) PDPK1ROCK1AURKBAURKAEGLN2
SCHEMBL1317539 0.91 PDPK1 (0.56) PDPK1ROCK1AURKBAURKAEGLN2
SCHEMBL1317711 0.91 PDPK1 (0.66) PDPK1ROCK1AURKBAURKAEGLN2
SCHEMBL1317282 0.91 PDPK1 (0.66) PDPK1ROCK1AURKBAURKAEGLN2
SCHEMBL1318592 0.91 PDPK1 (0.56) PDPK1ROCK1AURKBAURKAEGLN2
SCHEMBL1317895 0.91 PDPK1 (0.57) PDPK1ROCK1AURKBAURKAEGLN2
SCHEMBL13354858 0.89 PDPK1 (0.59) PDPK1ROCK1AURKBAURKAKDM4E
SCHEMBL1317911 0.89 PDPK1 (0.54) PDPK1ROCK1AURKBAURKAKDM4E
SCHEMBL1316877 0.89 PDPK1 (0.56) PDPK1ROCK1AURKBAURKAEGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2362775-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-08-05 EP disclosed
EP-2362775-B1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2015-08-05 EP disclosed
US-8697685-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2014-04-15 US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 US disclosed
US-20110275611-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275611-A1 CHEMICAL COMPOUNDS PDK1, PDK2, PDK3 PDPK1 12/4885ROCK1 266/4885AURKB 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.